RESEARCH TRIANGLE PARK, N.C. & SHERBROOKE, Quebec--(BUSINESS WIRE)--Tranzyme Pharma, a leading biopharmaceutical company developing small molecule drugs for the treatment of gastrointestinal (GI) and metabolic diseases, announced today that Vipin K. Garg, Ph.D., President and CEO, will present at the upcoming 26th Annual JPMorgan Healthcare Conference being held from January 7-10, 2008. Tranzyme’s presentation will take place on Monday, January 7, 2008 at 3:30 p.m. PST at the Westin St. Francis Hotel in San Francisco, CA.
